Patients Stopping Weight-Loss Injections Put On Pounds Far More Rapidly Compared to Dieters

New research indicates that individuals who stop using new weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who stop conventional diet and exercise programs.

Findings released in a major medical journal shows that while overweight individuals often shed substantial amounts of their body weight while on the medication, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.

"Users buying these drugs must be cognizant of the risk of rapid rebound weight gain when the medication ends," stated expert Dr. Susan Jebb.

This pace of regain implies a return to starting weight in about a year and a half.

Comparing Therapies

The study, which looked at dozens of studies involving thousands of patients, compared the effects of GLP-1 agonists with older methods.

The team emphasize that individuals who lose weight through dieting usually experience a more gradual weight regain—perhaps 0.1 kg a month—after stopping.

Explaining the Fast Regain

Doctors suggest the way of the drugs explains the heightened weight return.

These medications copy a natural hormone called GLP-1, which controls appetite.

"Long-term administration of the hormone concentrations far above than normal might result in the body to generate a reduced amount of its endogenous GLP-1, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this GLP-1 'fix' results in appetite is no longer kept in check, making overeating much more probable."

A Chronic Condition?

Health authorities recommend the injections for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.

Many experts contend that, given the likelihood of relapse, the therapy might need to be life-long.

This opinion is supported by drug manufacturers, who state that the results "emphasize the long-term character of excess weight," akin to managing conditions like high blood pressure.

User Experiences

Individuals who have stopped the jabs explain a intense return of appetite.

"I experienced a switch that goes on and you become starving," said a patient.

This challenge is compounded if patients have not developed sustainable dietary or behavioural modifications during treatment.

Widespread Use

Survey data suggest that millions of people in the UK have tried these injections in the last 12 months, with interest continuing to grow.

• Use is more common among females than males.
• The middle-aged age group shows the greatest usage rates.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

Finally, experts caution that while these medications are powerful agents for weight loss, they are not a magic cure and long-term success likely depends on integrated lifestyle management.